Amgen believes that it can transcend the expected tradeoff between convenience and efficacy, anticipating that its ...
Big Pharma delivered strong Q4 2025 results, with most companies beating revenue and EPS expectations and providing generally solid 2026 guidance. Eli Lilly solidified its leadership in obesity and ...
Zacks Investment Research on MSN
AMGN's Q4 Earnings & Sales Beat Estimates, Obesity Candidate in Focus
Amgen AMGN reported fourth-quarter 2025 adjusted earnings of $5.29 per share, which beat the Zacks Consensus Estimate of ...
Investor's Business Daily on MSN
Stock market divided with S&P 500, Nasdaq below key levels; Google, Amazon AI spending stuns: Weekly review
The stock market is divided, with the Nasdaq and S&P 500 breaking support but many sectors thriving. Google and Amazon AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results